Illumina Competitors and Similar CompaniesClear all
Illumina's competitors and similar companies include QIAGEN, Luminex, BGI Genomics, Thermo Fisher Scientific, Bruker and Natera.
 Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. |  Luminex Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians. |  BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services. |  Thermo Fisher Scientific Thermo Fisher Scientific is a company specializing in laboratory equipment, analytical instruments, reagents, consumables, and related technologies for scientific research and applied testing. |  Bruker Bruker is a company that develops, manufactures, and distributes scientific instruments and analytical and diagnostic services. |  Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | ||
Founding Date | Founding Date 1998 | Founding Date 1984 | Founding Date 1995 | Founding Date 1999 | Founding Date 1956 | Founding Date 1960 | Founding Date 2004 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more | Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more | Locations Austin, US HQ Toronto, CA Shanghai, CN Hong Kong, HK Saluggia, IT Tokyo, JP 's Hertogenbosch, NL see more | Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more | Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more | Locations Austin, US HQ San Carlos, US | |
Employees | Employees 8,6004% decrease | Employees 5,6541% decrease | Employees 1,007 | Employees 3,702 | Employees 125,000 | Employees 11,0853% decrease | Employees 3,28211% increase |
Valuation ($) | Valuation ($) 23.3 b | Valuation ($) 9.3 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) 209.2 b | Valuation ($) 8.9 b | Valuation ($) 15.4 b |
Financial | |||||||
Revenue (est.) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) $2.1b (FY, 2025) | Revenue (est.) $417.4m (FY, 2020) | Revenue (est.) ¥3.7b (FY, 2025) | Revenue (est.) $44.6b (FY, 2025) | Revenue (est.) $3.4b (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods $1.5b (FY, 2025) | Cost of goods $577.3m (FY, 2025) | Cost of goods $169.5m (FY, 2020) | Cost of goods ¥2.3b (FY, 2025) | Cost of goods $26.3b (FY, 2025) | Cost of goods $1.9b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $2.9b (FY, 2025) | Gross profit $1.5b (FY, 2025) | Gross profit $247.9m (FY, 2020) | Gross profit ¥1.4b (FY, 2025) | Gross profit $18.2b (FY, 2025) | Gross profit $1.6b (FY, 2025) | Gross profit N/A |
Net income | Net income $850m (FY, 2025) | Net income $437m (FY, 2025) | Net income $15.2m (FY, 2020) | Net income (¥637.8m) (FY, 2025) | Net income $6.7b (FY, 2025) | Net income ($8.6m) (FY, 2025) | Net income ($208.2m) (FY, 2025) |
Operating ⚠ | |||||||
Backlog | Backlog $657m (FY, 2024) | Backlog N/A | Backlog N/A | Backlog N/A | Backlog N/A | Backlog $2.1b (FY, 2022) | Backlog N/A |
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 100 (FY, 2022) | Countries 70 (FY, 2023) | Countries N/A | Countries N/A |
Facilities Leased, sq. ft. | Facilities Leased, sq. ft. 2.4 m (FY, 2024) | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. 445.7 k (FY, 2022) | Facilities Leased, sq. ft. 272 k (FY, 2021) |
Remaining Performance Obligations | Remaining Performance Obligations N/A | Remaining Performance Obligations $72m (FY, 2024) | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations $25.3b (Q3, 2024) | Remaining Performance Obligations $2.3b (FY, 2022) | Remaining Performance Obligations N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 28m | Total funding raised $ 4m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 500m | Total funding raised $ 24.5m | Total funding raised $ 154.1m |
For sources of this data, please see the company profile
View Company Profiles
QIAGEN
HQ
Venlo, NL
Employees
5,654↓ 1% decrease
QIAGEN is a company that provides sample technology solutions.
View companyLuminex
HQ
Austin, US
Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians.
View companyBGI Genomics
HQ
Shenzhen, CN
Employees
3,702
BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.
View companyThermo Fisher Scientific
HQ
Waltham, US
Employees
125,000
Thermo Fisher Scientific is a company specializing in laboratory equipment, analytical instruments, reagents, consumables, and related technologies for scientific research and applied testing.
View company